You are required to be logged in to access the full website
Click here if you have forgotten your username or password
Therapy Areas
6 February 2026 - Clinical-stage biotechnology company K36 Therapeutics Inc on Thursday announced completion of dosing in the first patient cohort of its Phase 1 clinical trial evaluating KTX-2001, a first-in-class, orally administered, selective NSD...
6 February 2026 - Biotechnology company Partner Therapeutics Inc (PTx) announced on Thursday that the US Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) to zenocutuzumab-zbco for the treatment of adults with advanced unre...
4 February 2026 - American specialty pharmaceutical company Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX) said on Wednesday it has received Fast Track Designation from the US Food and Drug Administration for ifetroban, an oral therapy targeting the ...
4 February 2026 - Women's health company Hologic Inc (Nasdaq:HOLX) announced on Wednesday that the US Food and Drug Administration (FDA) has approved its Aptima HPV Assay for clinician-collected HPV primary screening.The mRNA-based assay is desi...
4 February 2026 - Cizzle Biotechnology Holdings plc (LSE: CIZ), a UK-based developer of diagnostic tests for early-stage cancer, announce on Wednesday that it has been granted patent protection in Canada covering methods to measure the CIZ1B lung can...
4 February 2026 - Biosion Inc, a China-based clinical-stage biotechnology company developing innovative antibody-based therapeutics, announced on Tuesday that the first patient has been dosed in a Phase 1a/1b Investigator-Initiated Trial (IIT) assess...
4 February 2026 - US pharmaceutical company AbbVie (NYSE:ABBV) announced on Tuesday that it has submitted applications to the US Food and Drug Administration (FDA) and European Medicines Agency (EMA) for a new indication of upadacitinib (RINVOQ; 15 m...